Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00638651 · ClinicalTrials.gov registry record · Phase 1
Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00638651 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 3 participants.
The verdict
NCT00638651, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.
Interventions
- DEVICE 1064 nm Nd:YAG laser
- DRUG Imiquimod, 5% cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-02 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00638651
The ClinicalTrials.gov registry entry for NCT00638651 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 1064 nm Nd:YAG laser is the first listed.
NCT00638651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00638651 about?
NCT00638651 is a clinical study titled "Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal". The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.
What is the current status of trial NCT00638651?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2008-02. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00638651?
The interventions under investigation include: 1064 nm Nd:YAG laser (DEVICE), Imiquimod, 5% cream (DRUG).
Who is sponsoring clinical trial NCT00638651?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.